Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:TERN.O 14 January 2026

Terns Pharmaceuticals stock jumps 10% as JPM conference puts TERN-701 back on the map

Terns Pharmaceuticals stock jumps 10% as JPM conference puts TERN-701 back on the map

Terns Pharmaceuticals shares rose 10.4% to $38.03 by midday Wednesday after the company announced 2026 targets for its chronic myeloid leukemia drug at the JPMorgan Healthcare Conference. The company plans a pivotal dose selection and an FDA meeting by mid-2026, following early trial data showing a 75% major molecular response at 24 weeks. Investors are watching for longer-term results and regulatory milestones.
14 January 2026
··

Stock Market Today

  • Micron and FedEx Shine with Blowout Earnings Amid Market Turmoil
    March 20, 2026, 10:15 PM EDT. Micron Technology and FedEx reported strong quarterly earnings that stand out in a week marked by broader market declines fueled by surging oil prices and economic uncertainty linked to the Iran conflict. Micron's fiscal Q2 revenue soared nearly threefold to $23.86 billion, driven by high demand for AI-related memory products, topping earnings per share (EPS) estimates by over 38%. The company projects robust Q3 sales growth at $33.5 billion and anticipates exceeding $100 billion in annual sales next year. FedEx posted a fiscal Q3 EPS of $5.25, beating estimates by nearly 27%, supported by disciplined operations and digital efficiencies. It raised full-year EPS guidance to $19.30-$20.10, surpassing Wall Street forecasts. Both stocks could appeal to investors seeking buy-the-dip opportunities amid volatile trading.
Go toTop